VistaGen Therapeutics, Inc. (VTGN) Earnings
NASDAQ·Healthcare·Biotechnology
$0.67
+17.71%
Mkt Cap $18.72M
Awaiting Results
YesterdayTue, Jun 16, 2026
EPS Estimate
-$0.34
3 analysts
Revenue Estimate
$399.90K
Status
Awaiting actuals
Last quarter: beat by +11.76% on EPS, -16.86% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$18.72M
P/E
—
Fwd P/E
—
P/S
23.70
Rev TTM
—
EPS TTM
-$1.90